1. Home
  2. GKOS vs HAS Comparison

GKOS vs HAS Comparison

Compare GKOS & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • HAS
  • Stock Information
  • Founded
  • GKOS 1998
  • HAS 1923
  • Country
  • GKOS United States
  • HAS United States
  • Employees
  • GKOS N/A
  • HAS N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • HAS Recreational Games/Products/Toys
  • Sector
  • GKOS Health Care
  • HAS Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • HAS Nasdaq
  • Market Cap
  • GKOS 5.8B
  • HAS 9.6B
  • IPO Year
  • GKOS 2015
  • HAS N/A
  • Fundamental
  • Price
  • GKOS $102.90
  • HAS $76.40
  • Analyst Decision
  • GKOS Strong Buy
  • HAS Strong Buy
  • Analyst Count
  • GKOS 13
  • HAS 10
  • Target Price
  • GKOS $135.15
  • HAS $80.70
  • AVG Volume (30 Days)
  • GKOS 899.0K
  • HAS 2.5M
  • Earning Date
  • GKOS 07-30-2025
  • HAS 07-23-2025
  • Dividend Yield
  • GKOS N/A
  • HAS 3.66%
  • EPS Growth
  • GKOS N/A
  • HAS N/A
  • EPS
  • GKOS N/A
  • HAS 3.03
  • Revenue
  • GKOS $404,523,000.00
  • HAS $4,265,300,000.00
  • Revenue This Year
  • GKOS $27.88
  • HAS $3.16
  • Revenue Next Year
  • GKOS $27.60
  • HAS $4.15
  • P/E Ratio
  • GKOS N/A
  • HAS $25.28
  • Revenue Growth
  • GKOS 23.92
  • HAS N/A
  • 52 Week Low
  • GKOS $77.10
  • HAS $49.00
  • 52 Week High
  • GKOS $163.71
  • HAS $78.83
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 58.68
  • HAS 68.54
  • Support Level
  • GKOS $101.39
  • HAS $75.72
  • Resistance Level
  • GKOS $106.47
  • HAS $78.38
  • Average True Range (ATR)
  • GKOS 3.14
  • HAS 1.78
  • MACD
  • GKOS 0.06
  • HAS 0.30
  • Stochastic Oscillator
  • GKOS 65.46
  • HAS 79.27

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.

Share on Social Networks: